78
Participants
Start Date
October 1, 2017
Primary Completion Date
October 30, 2019
Study Completion Date
December 31, 2019
Propofol
For the maintenance of anesthesia, we used 2% propofol (Fresofol®, Fresenius Kabi, Germany) administered by the target controlled infusion (TCI) system (Orchestra® Base Primea; Fresenius Kabi, Germany) in Schnider mode with an effect concentration (Ce) of 2.5-3.5 µg ml-1
Sevoflurane
Anesthesia was maintained using 1-3% sevoflurane (ULTANE®, AbbVie Inc., USA) in the Sevoflurane group.
Taichung Veterans General Hospital, Taichung
Taichung Veterans General Hospital
OTHER